(Q43603245)

English

Inhibitory effect of silibinin on ligand binding to erbB1 and associated mitogenic signaling, growth, and DNA synthesis in advanced human prostate carcinoma cells

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Inhibitory effect of silibinin on ligand binding to erbB1 and associated mitogenic signaling, growth, and DNA synthesis in advanced human prostate carcinoma cells (English)

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

1 reference

based on heuristic

inferred from title

prostate carcinoma

1 reference

based on heuristic

inferred from title

author name string

Sharma Y

1

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Agarwal C

2

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Singh AK

3

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Agarwal R

4

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

publication date

1 April 2001

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Molecular Carcinogenesis

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

30

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

224-236

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Cell signaling and regulators of cell cycle as molecular targets for prostate cancer prevention by dietary agents

1 reference

https://api.crossref.org/works/10.1002%2FMC.1032

21 January 2018

Tyrosine kinase inhibition: an approach to drug development

1 reference

https://api.crossref.org/works/10.1002%2FMC.1032

21 January 2018

Expression of p160erbB-3 and p185erbB-2 in prostatic intraepithelial neoplasia and prostatic adenocarcinoma

1 reference

https://api.crossref.org/works/10.1002%2FMC.1032

21 January 2018

Growth factors and their receptors as determinants in the proliferation and metastasis of human prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FMC.1032

21 January 2018

Cancer chemoprevention: principles and prospects.

1 reference

https://api.crossref.org/works/10.1002%2FMC.1032

21 January 2018

Some perspectives on dietary inhibition of carcinogenesis: studies with curcumin and tea.

1 reference

https://api.crossref.org/works/10.1002%2FMC.1032

21 January 2018

The clinical evaluation of cancer prevention agents

1 reference

https://api.crossref.org/works/10.1002%2FMC.1032

21 January 2018

Recent advances in chemoprevention of cancer

1 reference

https://api.crossref.org/works/10.1002%2FMC.1032

21 January 2018

An overview of chemoprevention: current status and future prospects

1 reference

https://api.crossref.org/works/10.1002%2FMC.1032

21 January 2018

Antioxidants and multistage carcinogenesis in mouse skin

1 reference

https://api.crossref.org/works/10.1002%2FMC.1032

21 January 2018

Protection against microcystin-LR-induced hepatotoxicity by Silymarin: biochemistry, histopathology, and lethality.

1 reference

https://api.crossref.org/works/10.1002%2FMC.1032

21 January 2018

Inhibitory effect of a flavonoid antioxidant silymarin on benzoyl peroxide-induced tumor promotion, oxidative stress and inflammatory responses in SENCAR mouse skin

1 reference

https://api.crossref.org/works/10.1002%2FMC.1032

21 January 2018

Silibinin decreases prostate-specific antigen with cell growth inhibition via G1 arrest, leading to differentiation of prostate carcinoma cells: implications for prostate cancer intervention

1 reference

https://api.crossref.org/works/10.1002%2FMC.1032

21 January 2018

All ErbB receptors other than the epidermal growth factor receptor are endocytosis impaired

1 reference

https://api.crossref.org/works/10.1002%2FMC.1032

21 January 2018

Tissue distribution of silibinin, the major active constituent of silymarin, in mice and its association with enhancement of phase II enzymes: implications in cancer chemoprevention.

1 reference

https://api.crossref.org/works/10.1002%2FMC.1032

21 January 2018

Colonic Cl channel blockade by three classes of compounds

1 reference

https://api.crossref.org/works/10.1002%2FMC.1032

21 January 2018

Development and use of quantum mechanical molecular models. 76. AM1: a new general purpose quantum mechanical molecular model

1 reference

https://api.crossref.org/works/10.1002%2FMC.1032

21 January 2018

Clathrin, adaptors, and sorting

1 reference

https://api.crossref.org/works/10.1002%2FMC.1032

21 January 2018

Endocytosis and signals for internalization

1 reference

https://api.crossref.org/works/10.1002%2FMC.1032

21 January 2018

Clathrin assembly protein AP-2 induces aggregation of membrane vesicles: a possible role for AP-2 in endosome formation

1 reference

https://api.crossref.org/works/10.1002%2FMC.1032

21 January 2018

Skin cancer chemopreventive effects of a flavonoid antioxidant silymarin are mediated via impairment of receptor tyrosine kinase signaling and perturbation in cell cycle progression

1 reference

https://api.crossref.org/works/10.1002%2FMC.1032

21 January 2018

Inhibition of human carcinoma cell growth and DNA synthesis by silibinin, an active constituent of milk thistle: comparison with silymarin

1 reference

https://api.crossref.org/works/10.1002%2FMC.1032

21 January 2018

The ErbB signaling network: receptor heterodimerization in development and cancer

1 reference

https://api.crossref.org/works/10.1002%2FMC.1032

21 January 2018

Epidermal growth factor receptors: critical mediators of multiple receptor pathways

1 reference

https://api.crossref.org/works/10.1002%2FMC.1032

21 January 2018

Plasma insulin-like growth factor-I and prostate cancer risk: a prospective study

1 reference

https://api.crossref.org/works/10.1002%2FMC.1032

21 January 2018

Insulin-like growth factor physiology and cancer risk

1 reference

https://api.crossref.org/works/10.1002%2FMC.1032

21 January 2018

Randomized controlled trial of silymarin treatment in patients with cirrhosis of the liver

1 reference

https://api.crossref.org/works/10.1002%2FMC.1032

21 January 2018

Atomic Physicochemical Parameters for Three-Dimensional Structure-Directed Quantitative Structure-Activity Relationships I. Partition Coefficients as a Measure of Hydrophobicity

1 reference

https://api.crossref.org/works/10.1002%2FMC.1032

21 January 2018

Chemoprevention for prostatic intraepithelial neoplasia.

1 reference

https://api.crossref.org/works/10.1002%2FMC.1032

21 January 2018

Chemoprevention of prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FMC.1032

21 January 2018

Chemoprevention of prostate cancer: the Prostate Cancer Prevention Trial

1 reference

https://api.crossref.org/works/10.1002%2FMC.1032

21 January 2018

c-erbB-2 oncogene expression in prostatic intraepithelial neoplasia: mounting evidence for a precursor role

1 reference

https://api.crossref.org/works/10.1002%2FMC.1032

21 January 2018

Prevention of CCL4-induced liver cirrhosis by silymarin

1 reference

https://api.crossref.org/works/10.1002%2FMC.1032

21 January 2018

Protective effects of silymarin against photocarcinogenesis in a mouse skin model

1 reference

https://api.crossref.org/works/10.1002%2FMC.1032

21 January 2018

Novel cancer chemopreventive effects of a flavonoid antioxidant silymarin: inhibition of mRNA expression of an endogenous tumor promoter TNF alpha

1 reference

https://api.crossref.org/works/10.1002%2FMC.1032

21 January 2018

Modulation of mitogen-activated protein kinase activation and cell cycle regulators by the potent skin cancer preventive agent silymarin

1 reference

https://api.crossref.org/works/10.1002%2FMC.1032

21 January 2018

A new approach to analysis and display of local lipophilicity/hydrophilicity mapped on molecular surfaces

1 reference

https://api.crossref.org/works/10.1002%2FMC.1032

21 January 2018

Interaction of activated EGF receptors with coated pit adaptins

1 reference

https://api.crossref.org/works/10.1002%2FMC.1032

21 January 2018

Lipophilic beta-adrenoceptor antagonists stimulate low density lipoprotein receptor activity in human skin fibroblasts

1 reference

https://api.crossref.org/works/10.1002%2FMC.1032

21 January 2018

Identifiers

10.1002/MC.1032

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43603245&oldid=2101840758"